Media hub
-
Blood vessel breakdown linked with Alzheimer’s disease
Researchers at the Centenary Institute have discovered a connection between the health of blood vessels and the development of Alzheimer’s disease. The findings suggest that early interventions aimed at improving blood vessel health offer an avenue for the advancement of new treatments for Alzheimer’s. A progressive brain disorder, Alzheimer’s disease causes memory loss, cognitive decline ...News Type: Media releaseDate -
Research to unlock the secrets of muscle loss in ageing
The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap.News Type: Media releaseDate -
New treatment offers hope for advanced liver cancer
Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide.News Type: Media releaseDate -
Award to fund innovative CAR-T cell therapy research
Dr Mehdi Sharifi Tabar, a researcher from the Gene and Stem Cell Therapy Program at the Centenary Institute, has been announced as the recipient of the 2023 Kenyon Foundation Inflammation Award.News Type: Media releaseDate -
Funding for research into repairing a damaged heart
Research into repairing damaged heart muscle is set to be advanced with the Centenary Institute’s Dr Daniel Hesselson awarded a Cardiovascular Collaborative Grant worth $994,000 under the NSW Government’s Cardiovascular Research Capacity Program. Heart muscle damage resulting from a heart attack or cardiomyopathy (heart muscle disease) can lead to reduced heart function and life expectancy ...News Type: Media releaseDate -
New study uncovers potential therapeutic target for breast cancer
Research conducted at the Centenary Institute has unveiled crucial insights into the underlying molecular mechanisms of breast cancer. The findings could lead to a more effective treatment for the disease, which claims the lives of over 3,000 Australian women and men annually.News Type: Media releaseDate -
New funding to advance gene therapies
Researchers at the Centenary Institute and the Sydney Local Health District (SLHD) have been awarded $500,000 from CUREator, Australia’s national biotech incubator, to develop new technology to improve the safe and effective delivery of gene therapy.News Type: Media releaseDate -
How can cardiovascular healthcare be ‘greener’?
A new review has shown how medical professionals in cardiology can help reduce healthcare’s carbon footprint, by making small, low-cost changes in how they work. The review, published today in the prestigious Open Heart journal, explores the environmental impact of cardiovascular healthcare.News Type: Media releaseDate -
Key mechanism identified for reducing chronic inflammation in cardiovascular diseases
A breakthrough discovery in understanding how white blood cells move in the body could pave the way for new treatments for chronic inflammation-related diseases including cardiovascular diseases, according to a recent study from the Centenary Institute.News Type: Media releaseDate -
Centenary Institute announces new Executive Director – a coup to recruit a shining star from Melbourne’s WEHI
The Centenary Institute is delighted to announce that Professor Marc Pellegrini will join the Centenary Institute as its new Executive Director. A physician, immunologist and internationally renowned research scientist, Professor Pellegrini has over 20 years of experience working on chronic infections.News Type: Media releaseDate -
Discovery could open door to new COPD treatment
Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD) – the targeting and inhibition of a protein called RIPK1.News Type: Media releaseDate -
Grant supports new COVID-19 nasal vaccine research
Research led by the Centenary Institute and the University of Sydney – focused on the development of a new nasal COVID-19 vaccine – has received close to $1m in grant funding from the NSW COVID-19 Vaccine Acceleration Research Grants Program.News Type: Media releaseDate